Table 4 Surgical exploration and resection rates after neoadjuvant therapy

86%

76%

63%

92%

88%

[79–92%]

[68–84%]

[51–75%]

[85–97%]

[80–94%]

I ² = 83.91%

I ² = 86.02%

I ² = 90.69%

I ² = 83.37%

I ² = 81.82%

(n = 18)

(n = 18)

(n = 14)

(n = 18)

(n = 14)

77%

69%

54%

91%

84%

[66–86%]

[59–78%]

[37–71%]

[84–96%]

[67–96%]

I ² = 87.62%

I ² = 88.98%

I ² = 95.15%

I ² = 70.68%

I ² = 93.75%

(n = 15)

(n = 18)

(n = 16)

(n = 15)

(n = 16)

32%

26%

23%

86%

82%

[23–42%]

[19–34%]

[15–33%]

[73–95%]

[69–93%]

I ² = 91.44%

I ² = 89.42%

I ² = 91.18%

I ² = 86.04%

I ² = 82.75%

(n = 22)

(n = 24)

(n = 18)

(n = 19)

(n = 15)

65%

53%

39%

89%

85%

[49–79%]

[36–70%]

[27–52%]

[80–96%]

[79–90%]

I ² = 95.67%

I ² = 96.04%

I ² = 92.74%

I ² = 85.80%

I ² = 35.55%

(n = 20)

(n = 22)

(n = 20)

(n = 19)

(n = 19)

64%

55%

45%

91%

85%

[57% -71%]

[48–62%]

[38–52%]

[87–94%]

[80–89%]

I ² = 95.27%

I ² = 95.34%

I ² = 94.94%

I ² = 84.53%

I ² = 85.05%

(n = 84)

(n = 90)

(n = 74)

(n = 79)

(n = 70)